Interstitial lung disease associated to erlotinib treatment: a case report

INTRODUCTION: Few cases of pulmonary toxicity related to epidermal growth factor receptor-targeted agents have been described. CASE PRESENTATION: We report a case of a 63-year-old white male with stage IV non-small cell lung cancer treated with erlotinib who developed a interstitial lung disease. CO...

Descripción completa

Detalles Bibliográficos
Autores principales: del Castillo, Yolanda, Espinosa, Paulina, Bodí, Fernanda, Alcega, Raquel, Muñoz, Emma, Rabassó, Carlos, Castander, David
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834622/
https://www.ncbi.nlm.nih.gov/pubmed/20509858
http://dx.doi.org/10.1186/1757-1626-3-59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834622/
https://www.ncbi.nlm.nih.gov/pubmed/20509858
http://dx.doi.org/10.1186/1757-1626-3-59

Ejemplares similares